drugset / Trial / NCT06490939
Clinical Trial of Efepoetin Alfa in Healthy Subjects
Non-randomizedParallel-groupOpen-labelTreatment
Summary
An open-label, parallel-group, single-center, Phase I study to compare the pharmacokinetic/pharmacodynamic characteristics, safety, and tolerability of a single intravenous administration of Efepoetin Alfa in healthy subjects
Timeline
- Start
- 2024-10-29
- Primary completion
- 2025-03-25
- Completion
- 2025-03-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Efepoetin Alfa | Protein / enzyme biologic | — | Intravenous |
Indications
No indication recorded.